Doing Science | Page 3 | Student Science

Support Strong Science

Be a champion now for the

next generation of science leaders.

Doing Science

A blog for students who compete

Doing Science

Regeneron STS

Expect failure in science, learn from the challenging moments, say Regeneron scientists

11:58AM, March 16, 2018
Doing Science

Regeneron scientists described their jobs and the science they get to do every day with the finalists.

Failure is a constant and should be expected in science. It may even be where you learn the most. That's what Regeneron scientists told the Regeneron STS 2018 finalists Monday night at the Innovation Dinner.

George Yancopoulos, the President and Chief Scientific Officer at Regeneron, summed up the spirit of science at his company. "At Regeneron, we wanted to focus on the science and come up with new medicines — working on them from the beginning stages to the end — all within the same company," he said. "We already have six FDA-approved medicines that are really game-changing drugs."

George Yancopoulos, Regeneron's President and Chief Scientific Officer, told the finalists how he entered science.

"At Regeneron, we believe in science that can be translated to make improvements in people's lives," George said. "The pact we make with patients is so important. It's your responsibility now to use your talents to improve the world."

For the first part of the evening, the finalists met with several scientists who work on various projects at Regeneron. They put on VR headsets to see how macular degeneration and other eye diseases can affect vision. They discussed internships and opportunities. And they saw firsthand the successful science Regeneron has put out in the world.

During the evening, there was also a panel discussion with five Regeneron scientists from various backgrounds. The panelists discussed the often timely process of moving a drug through testing, trials, human trials, and then approval. Many medicines never come out of that pipeline. "I'm a very optimistic person, or else I couldn't do this. I wasn't surprised when we failed," said Neil Stahl, the Executive Vice President of Research and Development at Regeneron. During his tenure with Regeneron, he spearheaded the invention and development of Trap Technology, which provided the basis of Regeneron's first three approved drugs, and built the pre-clinical development team.

Bari Kowal, Regeneron's Vice President and Head of Global Clinical Project Management & Operations, speaks with the finalists at the reception.

Lori Morton, Regeneron's Senior Director of Cardiovascular Research and Fibrosis Research, agreed: "Science failures happen all the time. And it's data — you can't be angry at the data. Just ask a new question." Personal failure, however, happen as well. In graduate school, she was the victim of a colleague falsifying data. She had just joined Regeneron when the previous deception was revealed to her, and she had to write a retraction for Science. But she learned from the experience, instead of giving up and thinking her career was over.

"In academia, there's so much pressure to publish," she explained. "If it's a compelling story, it may be publishable, even if the story does not hold up over time. But if you want to make a drug that works and helps people, the only thing that matters is the truth."

The scientists explained that the reason they do all of their work, and keep pushing through all of the failures, is for the patients.

The finalists got a chance to speak with Regeneron scientists about the breakthroughs they're making in medicine.

Several of the Regeneron scientists made the transition from academia to industry in their careers. They touted industry's culture of discovery and support.

"Scientists are more collaborative in industry. Industry can be a great way to do science," said John Lin, the Vice President of Immuno-Oncology & Head of Bispecifics at Regeneron. John L. leads the bispecific antibody research and development programs at the company.

The other panelists agreed. "When I was in school, you were considered a failure if you went into industry," Neil said.

"You can just feel the excitement at Regeneron — we care about the science. The way we work is driven by the science," said Bari Kowal, Regeneron's Vice President and Head of Global Clinical Project Management & Operations. Bari is responsible for the global operational leadership for the clinical development of the company's pipeline of important new medicines. Her team manages over 5,000 clinical investigators and the collection of data from more than 20,000 clinical trial subjects in over 50 countries worldwide.

During the evening, the finalists had a chance to take fun photos with props.

"In academia, you have to deal with politics and legacy," said John Overton, the Executive Director and Head of Sequencing and Lab Operations at the Regeneron Genetics Center, which serves as "a nimble biotech company within a larger biotech company." John O. oversees the biobanking, sample processing, and sequencing of human DNA samples. Since 2014, the RGC lab has sequenced the exomes of nearly 300,000 patient volunteers.

At Regeneron, in addition to inspiration and invention from senior research leadership, the lab research scientists are the drivers of innovation for new drug targets, Lori said. "They're owning it and shepherding the whole process," she said. They champion their programs from target nomination through preclinical development and are critical team members in clinical development and beyond, and "this continuity of science goes a long way."

One major way Regeneron is able to retain its culture of discovery is that the critical conversations are conducted by scientists and clinicians, John L. explained. The company itself is led by scientists, instead of businesspeople.

1:08pm, December 19, 2017

At times, science research projects can be challenging. That’s where the Society for Science & the Public’s Advocate Grant Program comes in. The program helps mentors guide a group of three to five underrepresented students as they complete science research projects and apply to participate in science competitions.

A student works on her scientific research.
11:54am, December 8, 2017

We've seen some incredible teen scientists in 2017. This year, Science News for Students(SNS) reported on student scientists who are inventing better ways to detect blood type, buoys to alert swimmers of deadly rip tides, and more.

12:02pm, December 7, 2017

What does it mean to be a young woman in STEM? For some of the Society for Science & the Public alumni, it might mean going out in the field to study glaciers. For others it might mean encouraging other young girls to code or enter computer science. It means being an Olympic athlete and biology professor. It means having the power to change the world.

Below, read stories about incredible women in STEM.

2:23pm, December 6, 2017

The Society for Science & the Public is constantly crossing paths with talented young scientists. These STEM superstars are solving problems facing our world and delving into important research that will further our scientific knowledge.

Below, check out a sampling of some of our favorite stories from this year about young science innovators.

4:59pm, December 1, 2017

2:33pm, November 22, 2017

Thanksgiving is a time to reflect and give thanks for families, success, and even our challenges.

We at the Society are thankful for the contributions our distinguished alumni have made in their respective fields as well as the recognitions they have received. Something else we are grateful for: alumni who have had such positive experiences competing in the Science Talent Search, Intel International Science and Engineering Fair, and Broadcom MASTERS that they encouraged brothers, sisters, children, and grandchildren to participate.

2:37pm, November 21, 2017

Pests are a big threat to cotton production worldwide — especially in India. Increasing pest attacks in India, the largest producer of cotton in the world, have led to decreased production levels over the past few years.

One young Indian scientist is committed to solving the pest problem facing his community. Neelansh Gupta is researching a natural pesticide to combat the pests and save cotton plants.

9:00am, November 20, 2017
Sometimes, kids just need a chance to get out of the classroom. Luckily, BioBus offers a fun, interactive way to teach students about science in a new environment. After all, learning about science isn’t just confined to the classroom—it happens in the world around us.
Students participate in a lab on the BioBus.
Subscribe to RSS - Doing Science

From the SSP Newsroom

Science News


Science News for Students


Eureka! Lab